| 今开：41.97 | 昨收：41.99 |
| 最高：42.06 | 最低：41.93 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：7.627120126E9 |
Cerevel Therapeutics(CERE)02-09 08:25
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-012953 Size: 9 KB 网页链接查看全文
cooyee04-19 07:36
$Cerevel Therapeutics(CERE)$ 这一笔khan厉害，最后一天2nd request拖时间，拖到cere的帕金森药3期过了，这下真的跟$艾伯维公司(ABBV)$的药重叠了，这合并难了查看全文
Cerevel Therapeutics(CERE)03-01 05:25
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001555 Act: 33 Size: 5 KB 网页链接查看全文
Cerevel Therapeutics(CERE)03-05 06:55
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025036 Size: 8 KB 网页链接查看全文
Cerevel Therapeutics(CERE)02-28 05:05
$Cerevel Therapeutics(CERE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-021078 Act: 34 Size: 22 MB 网页链接查看全文
Cerevel Therapeutics(CERE)02-09 22:05
$Cerevel Therapeutics(CERE)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001193125-24-029317 Act: 34 Size: 36 KB 网页链接查看全文
Cerevel Therapeutics(CERE)02-14 05:25
$Cerevel Therapeutics(CERE)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-014586 Size: 4 KB 网页链接查看全文
Cerevel Therapeutics(CERE)03-05 06:45
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001800 Act: 33 Size: 6 KB 网页链接查看全文
Cerevel Therapeutics(CERE)03-07 05:25
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027156 Size: 8 KB 网页链接查看全文
Cerevel Therapeutics(CERE)04-02 04:35
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002798 Act: 33 Size: 7 KB 网页链接查看全文
智通财经APP获悉，艾伯维(ABBV.US)的收购标的Cerevel Therapeutics周四宣布，其每日一次的帕金森病口服候选药物tavapadon在一项作为联合疗法的关键性三期试验中达成主要目标。 该公司说，针对帕金森病晚期成... 网页链接
周四，Cerevel(CERE.US)股价走高，截至发稿，该股涨超12%，报41.47美元。艾伯维(ABBV.US)将以每股45美元的价格收购神经科学药物制造商Cerevel Therapeutics。 这笔交易是艾伯维在过去两周内的第二笔重大收购，此前这家制药巨头于11月30日表... 网页链接
智通财经APP获悉，美国医药巨头艾伯维(ABBV.US)当地时间周三表示，将以高达约87亿美元收购主攻神经科学领域的制药公司Cerevel Therapeutics(CERE.US)。根据收购交易条款， 艾伯维(AbbVie) 将以每股45美元的价格收购Cerevel。艾伯维表... 网页链接
艾伯维同意以87亿美元的价格收购Cerevel Therapeutics，这是该制药商上周宣布的第二笔重大收购。 艾伯维将以每股45美元的现金支付，较Cerevel周三的收盘价溢价22%。自上周末以来，这家生物技术公司的股价上涨了... 网页链接
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-041073 Size: 8 KB 网页链接
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-002798 Act: 33 Size: 7 KB 网页链接
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-027156 Size: 8 KB 网页链接
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-025036 Size: 8 KB 网页链接
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001800 Act: 33 Size: 6 KB 网页链接
$Cerevel Therapeutics(CERE)$ 144 Report of proposed sale of securities Accession Number: 0001950047-24-001555 Act: 33 Size: 5 KB 网页链接
$Cerevel Therapeutics(CERE)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0000950170-24-021078 Act: 34 Size: 22 MB 网页链接
$Cerevel Therapeutics(CERE)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001062993-24-003957 Size: 9 KB 网页链接
$Cerevel Therapeutics(CERE)$ 8-K Current report, items 5.07 and 8.01 Accession Number: 0001193125-24-038534 Act: 34 Size: 162 KB 网页链接
$Cerevel Therapeutics(CERE)$ 5 Annual statement of changes in beneficial ownership of securities Accession Number: 0000950170-24-014586 Size: 4 KB 网页链接